Health CatalystHCAT -1.71%49 FCF Margin % is 18.40% as of Mar. 2026. GuruFocus rates HCAT with a GF Score™ of 49/100 and a GF Value™ of $5.07 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Health Catalyst ranks worse than 62.18% on this metric.
The historical rank and industry rank for Health Catalyst's FCF Margin % or its related term are showing as below:
HCAT'
s FCF Margin % Range Over the Past 10 Years
Min: -54.97 Med: -19.07 Max: -0.6
Current: -0.91
During the past 9 years, the highest FCF Margin % of Health Catalyst was -0.60%. The lowest was -54.97%. And the median was -19.07%.
HCAT's FCF Margin % is ranked worse than 62.18% of 669
companies
in the Healthcare Providers & Services industry
Industry Median: 3.34
vs HCAT: -0.91
Health Catalyst FCF Margin % Related Terms
Health Catalyst FCF Margin % Historical Data
* Premium members only.
The historical data trend for Health Catalyst's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Health Catalyst's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Catalyst FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Health Catalyst's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst (HCAT) has a FCF Margin % of 18.40% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Health Catalyst and its competitors. According to the industry distribution chart, Health Catalyst ranks #416 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 62.2%.
Is Health Catalyst's FCF Margin % too high?
Health Catalyst's current FCF Margin % is 18.40%. The Healthcare Providers & Services industry median FCF Margin % is 3.34. Health Catalyst's value of 18.40% is 450.9% above this industry median. Based on the distribution chart, Health Catalyst ranks #416 out of 669 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's FCF Margin % compare to CCLD and DH?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #416 out of 669 companies for FCF Margin %. This places Health Catalyst in the lower half of its industry. The industry median FCF Margin % is 3.34. Health Catalyst's value of 18.40% is 450.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.34, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Catalyst's current FCF Margin % of 18.40% is 450.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Health Catalyst and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Catalyst's current FCF Margin % is 18.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.07, compared to a current price of $1.72 — trading 66.1% below its estimated fair value. The current FCF Margin % is 18.40% and 450.9% above the Healthcare Providers & Services industry median of 3.34. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Health Catalyst (HCAT), the current FCF Margin % is 18.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Catalyst (HCAT) Overvalued in 2026?
Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued.
The current stock price of $1.72 is trading 66.1% below its estimated GF Value™ of $5.07.
GuruFocus considers Health Catalyst to be Possible Value Trap.
Key valuation signals for HCAT:
FCF Margin %: 18.40%
GF Value™: $5.07 vs. price of $1.72 (66.1% below fair value)
Industry Position: 450.9% above the Healthcare Providers & Services median (#416 of 669)
No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score
Get the complete analysis for HCAT
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCAT has been successfully added to your 
